Cardica to Present at Source Capital Group’s 2016 Disruptive Growth and Healthcare Conference in New York on February 10th
February 04 2016 - 4:10PM
Cardica, Inc. (Nasdaq:CRDC) today announced that Julian Nikolchev,
the company’s president and CEO, with give a corporate overview and
update at Source Capital’s 2016 Disruptive Growth and Healthcare
Conference on Wednesday, February 10, 2016 at 4:00pm Eastern Time
in New York City.
For more information on the conference, or for investor
registration, please go to www.SourceCapitalConference.com. To
access the live and subsequently archived webcast of the
presentation, go to the Investor Relations section of the company's
website at http://www.cardica.com. Please connect to the website at
least 15 minutes prior to the presentation to allow for any
necessary software downloads.
About Source Capital Group
Source Capital Group, Inc. was founded in 1992 on the belief
that the best investment advice should be independent, unbiased and
tailor-made for the individual client’s needs. Source Capital began
as a boutique investment banking firm specializing in small to
medium sized transactions. We have grown to include businesses in
general securities, emerging market securities, distressed and high
yield debt securities, in addition to our investment banking
activity. http://www.sourcegrp.com/
About CardicaCardica designs and
manufactures proprietary stapling and anastomotic devices for
cardiac and minimally invasive surgical procedures. Cardica's
technology portfolio is intended to reduce operating time and
facilitate minimally invasive and robot-assisted surgeries.
Cardica’s MicroCutter XCHANGE® 30, that includes a cartridge-based
articulating surgical stapling device with a five-millimeter shaft
diameter and staples, is manufactured and cleared for use in the
United States for transection and resection in multiple open or
minimally invasive urologic, thoracic and pediatric surgical
procedures, as well as application for transection, resection
and/or creation of anastomoses in the small and large intestine and
the transection of the appendix. The MicroCutter XCHANGE 30 white
cartridge staple has application in vascular tissue. In
addition, Cardica manufactures and markets its automated
anastomosis systems, the C-Port® Distal Anastomosis Systems and
PAS-Port® Proximal Anastomosis System for coronary artery bypass
graft (CABG) surgery, and has shipped over 57,500 units throughout
the world.
Contact:
Bob Newell
Vice President, Finance and Chief Financial Officer
(650) 331-7133
investors@cardica.com